2019 Global Biopharmaceutical CDMO Development Summit Forum - Cell and Gene Therapy Conference Sharing

Against the backdrop of the trend of biopharmaceutical innovation in China, new types of CDMO demand for drugs have gradually emerged from the mature demand for antibody drugs, such as CAR-T cell therapy, gene therapy, novel antibody therapy, microbial drugs, exosomal drugs, and so on. Many excellent enterprises have also emerged in these fields. There are still many problems to be solved in the industry.

From August 3rd to 4th, Yimaike will invite leading CDMO companies and related biopharmaceutical companies to hold the "First Global Biopharmaceutical CDMO Development Summit Forum" to jointly explore the technology sharing and development transformation of innovative drug CDMO. 

Time: August 3-4, 2019

Location: Sheraton Suzhou Fupeng Hotel

Organizer: Medical Maike

Co organizers: Xingyao Research Institute, Fengke Interview, Letu Youjia Pharmaceutical
Conference scale: 700+
Attendees: 60% of biopharmaceutical companies, 30% of CRO/CDMO companies, and 10% of investment institutions